Issue Information - Forthcoming Papers
Subclonal heterogeneity in chronic lymphocytic leukaemia: revealing the importance of the lymphoid tumour microenvironment
Gouty tophi in the bone marrow
Massive haemolysis and erythrophagocytosis in Gram-negative sepsis
Current status of chimeric antigen receptor therapy for haematological malignancies
New products for the treatment of haemophilia
Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma
TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status
Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients
Myeloma impairs mature osteoblast function but causes early expansion of osteo-progenitors: temporal changes in bone physiology and gene expression in the KMS12BM model
Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen
Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial
Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia
Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid
Rifampicin-dependent antibodies target glycoprotein IIb/IIIa and cause clearance of human platelets in NOD/SCID mice
Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells
Thrombotic risk in patients with immune haemolytic anaemia
Corrigendum
Corrigendum